APGE news · APGE stock

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock Is Falling.

Yahoo Finance · Jul 31, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)

AbbVie slashes its full-year guidance to account for its pending acquisition of Apogee Therapeutics.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.